Molecular targeting works by identifying genetic mutations and biomarkers that are unique to cancer cells. These targets can be proteins, genes, or other molecules that contribute to cancer cell survival and proliferation. Targeted therapies are developed to specifically bind or inhibit these molecules, thereby halting cancer progression.
